Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
HUMACompany Name
HUMACYTE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQHUMACYTE INC - Enterprise Value over EBIT Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
HUMA - EV/EBIT Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
|---|---|---|---|
| 6/30/2025 | $ -48.17M | $ 271.78M | 0 |
| 3/31/2025 | $ -67.2M | $ 237.51M | 0 |
| 12/31/2024 | $ -139.42M | $ 249.22M | 0 |
| 9/30/2024 | $ -144.37M | $ 736.07M | 0 |
| 6/30/2024 | $ -132.14M | $ 778.12M | 0 |
| 3/31/2024 | $ -98.99M | $ 613.6M | 0 |
| 12/31/2023 | $ -104.18M | $ 347.41M | 0 |
| 9/30/2023 | $ -82.88M | $ 185.69M | 0 |
| 6/30/2023 | $ -81.99M | $ 359.59M | 0 |
| 3/31/2023 | $ -22.64M | $ 331.16M | 0 |
Key Performance Insights, Last 5 Years
- HUMACYTE INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
- Over the past 5 years, HUMACYTE INC's average EV/EBIT has been 7.92.
- The median EV/EBIT for HUMACYTE INC during this period was 7.92
- HUMACYTE INC reached its highest EV/EBIT over the past 5 years at 10.3.
- The lowest EV/EBIT recorded by HUMACYTE INC in the same timeframe 5.54
HUMACYTE INC's EV/EBIT vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBIT Benchmarks
Similar metrics to EV/EBIT:
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Enterprise Value over EBIT
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].EV / EBIT
(=) EV/EBIT EV/EBIT for HUMACYTE INC is calculated as follows: EV [ $ 126.04M ] / EBIT [ $ 0 ]
(=) EV/EBIT [ 0 ] HUMA - Enterprise Value over EBIT, Last 5 years
5.54
Minimum
Sep 30, 2022
10.3
Maximum
Jun 30, 2022
7.92
Average
7.92
Median
EV/EBIT Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
| filtered constituents | 2.25K |
|---|---|
| min | 0.05 |
| max | 62.03 |
| average | 19.91 |
| median | 16.78 |
| std | 12.32 |